Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Far View Capital Management. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+5.13%
YTD+0.91%
Annualized+4.58%
Positioning StanceNEUTRAL
Market CapSmallCap
GeographyEurope, US
Digest Analysis
Quick Take
"Benefiting from Westwing's turnaround and UNFI's cyberattack recovery, offset by Sanuwave's wound-care market disruption and Russell 2000 removal."
Executive Summary
Far View Partners generated a net return of +0.91% in H1 2026, comprised of -4.01% in Q1 and +5.13% in Q2, bringing since-inception returns to +93.27% with a 4.49% CAGR. Performance benefited from strong results at Westwing, continued recovery at United Natural Foods following a cyberattack, and a private investment in Ingenuity. These gains were offset by substantial losses in Sanuwave, where CMS audit-driven disruptions in the wound-care market led to a guidance cut coinciding with Russell 2000 removal, and setbacks at Lifecore Biomedical due to customer shifts and product delays. The manager established a new position in Upsales Technology AB, a Swedish CRM software provider, after identifying that a planned demerger of its AI subsidiary had obscured the core business's profitability inflection to 35%+ EBITDA margins. Acquired at a double-digit free cash flow yield, the position was built to mid-sized after extensive diligence confirmed durable competitive advantages. Despite momentum-driven markets favoring recent winners, the manager remains committed to finding overlooked companies through deep research and patient capital deployment, maintaining full investment with currency hedges at quarter-end.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
78%
CautiousHigh
High Conviction (78%)
The manager demonstrates high conviction through concentrated positioning and specific, sized holdings. He names five individual equity positions with detailed commentary, including position sizing language ('mid-sized position' for Upsales, 'added to our position' for Sanuwave). The Upsales discussion is particularly conviction-rich: acquired at a double-digit free cash flow yield, built up during the quarter after extensive diligence including C-suite conversations and an on-site visit, with clear falsifiable catalysts around margin expansion and revenue growth. The manager states he 'dropped every other project' to pursue the Upsales opportunity and is willing to hold through volatility (adding to Sanuwave despite substantial losses). The portfolio is fully invested across 5+ named positions, suggesting concentration without extreme concentration. Some hedging language exists ('if the investment thesis is correct') but the directional bets are unmistakable and backed by specific fundamental work.
Growth Outlook
15%
BearishBullish
Bearish (15%)
The manager acknowledges that H1 2026 was driven by momentum, with the iShares MSCI USA Momentum Index enjoying its best quarter ever in Q2 2026. While he recognizes momentum is real and can persist, he expresses no enthusiasm for this market environment and notes it does not favor his value-oriented approach. He makes no predictions about when momentum leadership will fade, suggesting a neutral to mildly cautious view on the current market opportunity set for his strategy. The tone is observational rather than optimistic or pessimistic about broader markets.
Risk Appetite
55%
DefensiveAggressive
Balanced (55%)
The portfolio was fully invested at quarter-end, indicating a risk-on posture. The manager established a new position in Upsales and built it to mid-sized during the quarter, demonstrating active deployment. He also added to the Sanuwave position in late June despite substantial losses, showing willingness to increase exposure to high-conviction ideas. Currency hedges are maintained but the core equity exposure is maximum, reflecting a constructive risk appetite despite challenging market conditions for the strategy.
Capital Deployment
45%
De-riskingDeploying
Net Neutral (45%)
The manager established a new position in Upsales and built it to mid-sized during Q2 2026, indicating active deployment. He also added to the Sanuwave position in late June. The portfolio was fully invested at quarter-end. However, no specific cash level changes are disclosed, and the deployment activity appears to be rotation and selective additions rather than a significant reduction in cash reserves. The letter describes 'finding overlooked companies' as an ongoing activity but does not indicate aggressive drawdown of cash or leverage deployment. The activity level suggests moderate net deployment through position building and additions, but without cash percentage data, this scores in the moderate positive range rather than aggressive deployment territory.
Forward Guidance
40%
CautiousExpansionary
Neutral (40%)
The manager states he will continue doing what he believes he does best: finding overlooked companies, doing the work, and being patient. This indicates a steady-state approach rather than aggressive deployment or defensive pullback. He expresses optimism about specific holdings like Sanuwave's mid-term prospects and Upsales' potential for materially higher share prices over multi-year periods, but frames this as requiring patience. The forward stance is selectively constructive but not urgently bullish, suggesting a moderate positive bias with emphasis on waiting for theses to play out.
Language Signal
30%
BearishBullish
Bearish (30%)
The letter contains balanced directional language. Bullish terms include 'strong results,' 'better-than-expected,' 'continued progress,' 'optimistic,' 'attractive,' 'well positioned,' 'high-quality,' 'unique competitive advantages,' and 'materially higher share price.' Bearish language includes 'substantial losses,' 'suffered,' 'disruption,' 'hurt,' 'delayed,' 'drifted,' and acknowledgment of 'risks.' The manager discusses both winners and losers in detail. Overall, the language leans mildly positive as the manager frames setbacks as temporary while expressing confidence in long-term theses, but the balance of positive and negative commentary keeps this in moderate territory.
Perceived Risk
52%
Low RiskElevated
Moderate Risk (52%)
The manager identifies several specific risks with meaningful discussion. He describes industry-specific disruption in the wound-care market from CMS audits leading to practitioner bankruptcies and gray markets. He notes the challenge of momentum-driven markets that do not favor his value approach. He acknowledges that passive selling pressure from Russell 2000 removal compounded fundamental challenges at Sanuwave. Customer concentration risk is mentioned at Lifecore. However, these risks are discussed in the context of specific holdings rather than as systemic threats to the portfolio or market. The manager does not express alarm or frame these as existential risks, instead treating them as navigable challenges. The risk discussion is present and specific but not dominant in the letter's narrative, placing this in the moderate range.
Opportunity Density
68%
ScarceAbundant
Abundant (68%)
The manager demonstrates he is finding attractive opportunities despite challenging market conditions. He established a new position in Upsales at what he describes as a double-digit free cash flow yield, characterizing it as a 'significant mispricing' created by an unusual corporate structure. He states the portfolio was fully invested at quarter-end, suggesting sufficient opportunities to deploy capital. He expresses optimism about Sanuwave's mid-term prospects and added to the position. The letter describes an active process of finding overlooked companies, and the manager's AI-driven filter is generating actionable ideas. While he acknowledges momentum-driven markets don't favor his approach, he does not characterize the opportunity set as scarce or expensive. The tone suggests selective but meaningful opportunities exist for patient, research-intensive investors.
Time Horizon
72%
Short-TermLong-Term
Decade+ (72%)
The manager explicitly frames his approach as patient and multi-year. He describes Sanuwave's opportunity as 'mid-term' and states Upsales could deliver materially higher share prices 'over a multi-year period.' He emphasizes he will keep 'finding overlooked companies, doing the work, and being patient' and states he will not abandon his approach to chase recent momentum. The letter discusses holding through volatility (adding to Sanuwave despite losses) and waiting for theses to play out. However, the manager also discusses near-term catalysts like quarterly results and demerger events, and monitors company-specific milestones. The horizon is clearly multi-year but not permanent capital or decade-plus, placing this in the 2-5 year range typical of concentrated value investors who expect catalysts to materialize over several years rather than quarters.